Pasithea Therapeutics Corp. (KTTA) stock
KTTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.48−0.00 (-0.48%)
Close on Nov 20, 2026Market cap $16.00MP/E –Yield –
Pasithea Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Pasithea Therapeutics's revenue for the twelve months ending Dec 31, 2022 was $486.56K. For fiscal 2022 it was $486.56K, up 3130.4% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $486.56K | +3130.4% |
| FY2021 | Dec 31, 2021 | $15.06K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $240.71K | – |
| Q3 FY2022 | Sep 30, 2022 | $218.61K | – |
| Q2 FY2022 | Jun 30, 2022 | $13.58K | – |
| Q1 FY2022 | Mar 31, 2022 | $13.66K | – |
See a number that looks wrong?